Guangzhou Wondfo Biotech Co.,Ltd (SHE:300482)
China
· Delayed Price · Currency is CNY 19.46
+0.23 (1.20%)
At close: Mar 6, 2026
SHE:300482 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Operating Revenue | 2,569 | 3,060 | 2,760 | 5,674 | 3,354 | 2,805 | Upgrade
|
| Other Revenue | 5.07 | 5.07 | 5.22 | 6.89 | 7.11 | 5.82 | Upgrade
|
| Revenue | 2,574 | 3,065 | 2,765 | 5,681 | 3,361 | 2,811 | Upgrade
|
| Revenue Growth (YoY) | -12.52% | 10.85% | -51.33% | 69.01% | 19.57% | 35.64% | Upgrade
|
| Cost of Revenue | 980.78 | 1,107 | 1,040 | 2,747 | 1,396 | 870.75 | Upgrade
|
| Gross Profit | 1,593 | 1,957 | 1,725 | 2,933 | 1,965 | 1,940 | Upgrade
|
| Selling, General & Admin | 911.12 | 905.85 | 877.11 | 1,157 | 910.24 | 819.99 | Upgrade
|
| Research & Development | 405.43 | 411.52 | 378 | 418.84 | 391.09 | 279.43 | Upgrade
|
| Other Operating Expenses | 37.67 | 14.03 | 9.51 | 15.95 | 9.04 | 9.63 | Upgrade
|
| Operating Expenses | 1,377 | 1,367 | 1,268 | 1,609 | 1,330 | 1,115 | Upgrade
|
| Operating Income | 215.87 | 590.27 | 456.73 | 1,324 | 634.64 | 825.49 | Upgrade
|
| Interest Expense | -32.98 | -30.47 | -29.93 | -32.53 | -27.76 | -11.14 | Upgrade
|
| Interest & Investment Income | 20.91 | 20.53 | 58.71 | 64.93 | 50.48 | 40.51 | Upgrade
|
| Currency Exchange Gain (Loss) | 11.46 | 11.46 | 10.99 | 30.58 | -20.62 | -23.62 | Upgrade
|
| Other Non Operating Income (Expenses) | -2.19 | -4.16 | -0.59 | -6.59 | -5.67 | -3.96 | Upgrade
|
| EBT Excluding Unusual Items | 213.08 | 587.63 | 495.91 | 1,381 | 631.08 | 827.28 | Upgrade
|
| Impairment of Goodwill | - | - | -3.95 | -38.56 | -5.87 | -71.74 | Upgrade
|
| Gain (Loss) on Sale of Investments | 26.38 | 25.75 | 14.8 | 12.81 | 10.55 | 0.24 | Upgrade
|
| Gain (Loss) on Sale of Assets | 0.02 | 0.76 | 0.08 | -10.4 | -10.34 | -2.51 | Upgrade
|
| Asset Writedown | -13.8 | -5.96 | -10.77 | -29.96 | - | -44.37 | Upgrade
|
| Other Unusual Items | 37.56 | 21.29 | 44.7 | 50.11 | 55.07 | 22.04 | Upgrade
|
| Pretax Income | 263.25 | 629.46 | 540.76 | 1,365 | 680.49 | 730.93 | Upgrade
|
| Income Tax Expense | 11.41 | 64.25 | 53.33 | 174.41 | 47.91 | 114.13 | Upgrade
|
| Earnings From Continuing Operations | 251.83 | 565.22 | 487.43 | 1,190 | 632.58 | 616.81 | Upgrade
|
| Minority Interest in Earnings | 7.6 | -3.59 | 0.2 | 6.94 | 1.85 | 17.36 | Upgrade
|
| Net Income | 259.43 | 561.63 | 487.62 | 1,197 | 634.43 | 634.17 | Upgrade
|
| Net Income to Common | 259.43 | 561.63 | 487.62 | 1,197 | 634.43 | 634.17 | Upgrade
|
| Net Income Growth | -50.47% | 15.18% | -59.27% | 88.68% | 0.04% | 63.67% | Upgrade
|
| Shares Outstanding (Basic) | 475 | 464 | 443 | 442 | 444 | 440 | Upgrade
|
| Shares Outstanding (Diluted) | 475 | 464 | 443 | 442 | 444 | 440 | Upgrade
|
| Shares Change (YoY) | 2.81% | 4.71% | 0.36% | -0.44% | 0.74% | -0.33% | Upgrade
|
| EPS (Basic) | 0.55 | 1.21 | 1.10 | 2.71 | 1.43 | 1.44 | Upgrade
|
| EPS (Diluted) | 0.55 | 1.21 | 1.10 | 2.71 | 1.43 | 1.44 | Upgrade
|
| EPS Growth | -51.82% | 10.00% | -59.41% | 89.51% | -0.69% | 64.22% | Upgrade
|
| Free Cash Flow | 9.38 | 43.5 | -104.05 | 1,099 | 208.44 | 642.33 | Upgrade
|
| Free Cash Flow Per Share | 0.02 | 0.09 | -0.23 | 2.49 | 0.47 | 1.46 | Upgrade
|
| Dividend Per Share | 0.400 | 0.400 | 0.400 | 0.500 | 0.300 | 0.385 | Upgrade
|
| Dividend Growth | - | - | -20.00% | 66.67% | -22.00% | 100.00% | Upgrade
|
| Gross Margin | 61.89% | 63.87% | 62.37% | 51.64% | 58.46% | 69.02% | Upgrade
|
| Operating Margin | 8.39% | 19.26% | 16.52% | 23.31% | 18.88% | 29.37% | Upgrade
|
| Profit Margin | 10.08% | 18.32% | 17.64% | 21.07% | 18.88% | 22.56% | Upgrade
|
| Free Cash Flow Margin | 0.36% | 1.42% | -3.76% | 19.35% | 6.20% | 22.85% | Upgrade
|
| EBITDA | 387.89 | 796.73 | 709.1 | 1,569 | 817.3 | 965.33 | Upgrade
|
| EBITDA Margin | 15.07% | 26.00% | 25.65% | 27.62% | 24.32% | 34.34% | Upgrade
|
| D&A For EBITDA | 172.01 | 206.45 | 252.37 | 244.63 | 182.66 | 139.85 | Upgrade
|
| EBIT | 215.87 | 590.27 | 456.73 | 1,324 | 634.64 | 825.49 | Upgrade
|
| EBIT Margin | 8.39% | 19.26% | 16.52% | 23.31% | 18.88% | 29.37% | Upgrade
|
| Effective Tax Rate | 4.33% | 10.21% | 9.86% | 12.78% | 7.04% | 15.61% | Upgrade
|
| Revenue as Reported | 2,574 | 3,065 | 2,765 | 5,681 | 3,361 | 2,811 | Upgrade
|
| Advertising Expenses | - | - | - | - | - | 221.25 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.